These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32272156)

  • 1. Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures.
    Lech Pedersen N; Mertz Petersen M; Ladd JJ; Lampe PD; Bresalier RS; Davis GJ; Demuth C; Jensen SØ; Andersen CL; Ferm L; Christensen IJ; Nielsen HJ
    Clin Chim Acta; 2020 Aug; 507():39-53. PubMed ID: 32272156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
    Wilhelmsen M; Christensen IJ; Rasmussen L; Jørgensen LN; Madsen MR; Vilandt J; Hillig T; Klaerke M; Nielsen KT; Laurberg S; Brünner N; Gawel S; Yang X; Davis G; Heijboer A; Martens F; Nielsen HJ
    Int J Cancer; 2017 Mar; 140(6):1436-1446. PubMed ID: 27935033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological cancer-associated protein biomarker levels at bowel endoscopy: Increased risk of subsequent primary malignancy.
    Piper TB; Nielsen HJ; Christensen IJ
    Tumour Biol; 2022; 44(1):1-16. PubMed ID: 35180141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Detection and Recurrence of Colorectal Adenomas by Combination of Eight Cancer-Associated Biomarkers in Plasma.
    Rasmussen L; Nielsen HJ; Christensen IJ
    Clin Exp Gastroenterol; 2020; 13():273-284. PubMed ID: 32884322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein and glycomic plasma markers for early detection of adenoma and colon cancer.
    Rho JH; Ladd JJ; Li CI; Potter JD; Zhang Y; Shelley D; Shibata D; Coppola D; Yamada H; Toyoda H; Tada T; Kumada T; Brenner DE; Hanash SM; Lampe PD
    Gut; 2018 Mar; 67(3):473-484. PubMed ID: 27821646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel method for screening colorectal cancer by infrared spectroscopy of peripheral blood mononuclear cells and plasma.
    Barlev E; Zelig U; Bar O; Segev C; Mordechai S; Kapelushnik J; Nathan I; Flomen F; Kashtan H; Dickman R; Madhala-Givon O; Wasserberg N
    J Gastroenterol; 2016 Mar; 51(3):214-21. PubMed ID: 26112122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals.
    Nielsen HJ; Brünner N; Jorgensen LN; Olsen J; Rahr HB; Thygesen K; Hoyer U; Laurberg S; Stieber P; Blankenstein MA; Davis G; Dowell BL; Christensen IJ; ;
    Scand J Gastroenterol; 2011 Jan; 46(1):60-9. PubMed ID: 20799911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer (†).
    Hvolris MH; Piper TB; Hammer E; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Christensen IJ; Brünner N; Johansen JS; Davis GJ; Dowell BL; Nielsen HJ
    Scand J Gastroenterol; 2016 Jul; 51(7):860-5. PubMed ID: 26918701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?
    Piper TB; Jørgensen LN; Olsen J; Nielsen KT; Davis G; Johansen JS; Jarle Christensen I; Nielsen HJ
    Acta Oncol; 2019; 58(sup1):S42-S48. PubMed ID: 30523734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
    Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
    Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.
    Christensen IJ; Brünner N; Dowell B; Davis G; Nielsen HJ; Newstead G; King D
    Anticancer Res; 2015 Sep; 35(9):4935-41. PubMed ID: 26254391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of algorithm development approaches: Development of biomarker panels for early detection of colorectal lesions.
    Gawel SH; Lucht M; Gomer H; Treado P; Christensen IJ; Nielsen HJ; Davis GJ;
    Clin Chim Acta; 2019 Nov; 498():108-115. PubMed ID: 31419412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.
    Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X
    Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different bowel preparation schedule leads to different diagnostic yield of proximal and nonpolypoid colorectal neoplasm at screening colonoscopy in average-risk population.
    Chiu HM; Lin JT; Lee YC; Liang JT; Shun CT; Wang HP; Wu MS
    Dis Colon Rectum; 2011 Dec; 54(12):1570-7. PubMed ID: 22067187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR.
    Cavallone L; Aldamry M; Lafleur J; Lan C; Gonzalez Ginestet P; Alirezaie N; Ferrario C; Aguilar-Mahecha A; Basik M
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):909-916. PubMed ID: 30824523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma.
    Yuan C; Yang K; Tang H; Chen D
    Onco Targets Ther; 2016; 9():3381-6. PubMed ID: 27350753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples.
    Thomas DS; Fourkala EO; Apostolidou S; Gunu R; Ryan A; Jacobs I; Menon U; Alderton W; Gentry-Maharaj A; Timms JF
    Br J Cancer; 2015 Jul; 113(2):268-74. PubMed ID: 26035703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.
    Barták BK; Kalmár A; Galamb O; Wichmann B; Nagy ZB; Tulassay Z; Dank M; Igaz P; Molnár B
    Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Cell Free DNA Integrity Index as a Biomarker for Response to Chemotherapy in Patients with Metastatic Colorectal Carcinoma.
    Eskander NS; Mansour L; Abdelaal A; Saad E; Mohamed D
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):339-348. PubMed ID: 35092403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.